Enrichment of Lactic Acid-Producing Bacteria in the Fecal Microbiota of Patients with Ulcerative Colitis in North India

Table 1

Baseline characteristics of the enrolled population.

	Ulcerative colitis ()	Healthy controls ()
Age (years) ()
Males () (%)	55 (52.38)	21 (58.33)
Disease duration (years) (median, IQR)	1 (0.5-4)
Disease extent () (%)
Proctitis	28 (26.66)
Left-sided colitis	57 (54.28)
Pancolitis	20 (19.04)
Disease activity () (%)
Active disease	64 (60.95)
Remission	41 (39.04)
Concomitant therapy () (%)
5-ASA	105 (100)
Thiopurines	49 (46.66)
Corticosteroids	66 (62.85)
Biologics	9 (8.57)

IQR: interquartile range; 5-ASA: 5-aminosalicylates. A patient can be on combination of two or more therapies.